Renovascular hypertension from the BCR‐ABL tyrosine kinase inhibitor ponatinib

Drug‐induced hypertension is one of the commonest causes of secondary hypertension. In the last few years, secondary hypertension due to tyrosine kinase inhibitors, from the vascular endothelial growth factor class, has been recognized to be an important cause of hypertension, as well as proteinuria...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Hypertens (Greenwich)
Hauptverfasser: Amin, Syed O., Ruzicka, Marcel, Burns, Kevin D., Bence‐Bruckler, Isabelle A., Ryan, Stephen E., Hadziomerovic, Adnan, Hiremath, Swapnil
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Short Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029973/
https://ncbi.nlm.nih.gov/pubmed/32175644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13843
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge